D2.285 - Baked egg oral Immunotherapy as an alternative in patients who failed raw egg oral immunotherapy

Poster abstract

Background

Egg allergy is one of the most common food allergies and may persist in a significant proportion of patients. Raw egg oral immunotherapy (OIT-REW) is effective in inducing desensitization; however, adverse reactions are frequent and may lead to treatment discontinuation in some patients, highlighting the need for alternative therapies.

Objective

To report our experience with 12 patients who failed OIT-REW and were subsequently transitioned to baked egg oral immunotherapy (OIT-BE).

Method

A retrospective analysis was conducted in 12 patients with IgE-mediated egg allergy who initiated OIT-REW but were switched to OIT-BE due to the severity and/or frequency of reactions. We analyzed the up-dosing phase, number and severity of reactions during both OIT protocols.

Reaction severity was classified using the Ordinal Food Allergy Severity Score (oFASS-5).

Results

The median age was 8.5 years, and 50% were female. Atopic dermatitis was present in 91.7% of patients and 58.3% had other food allergies. Prior to OIT initiation, 58.3% had asthma and 25% had rhinoconjunctivitis.

The median duration of OIT-REW was 14.5 days [3.75-99.75], with a maximum tolerated dose of 82.5 mg [26.9-247.5]. OIT-REW was discontinued in all patients due to the number of reactions. The median duration of OIT-BE was 134 days [68-232.25], with no treatment discontinuations and a maximum tolerated dose of 3630 mg. During both OIT protocols, pre-treatment included antihistamines in 9 patients (75%), inhaled corticosteroids plus long-acting beta-agonists in 7 (58.3%), and montelukast in 3 (25%). Concomitant treatment included antihistamines in 3 patients (25%).

During the up-dosing phase, 91 adverse reactions (ARs) were recorded: 76 during OIT-REW and 15 during OIT-BE. All patients experienced ARs during OIT-REW, with a median of 3 ARs per patient [2-6.5], whereas 10 patients reacted during OIT-BE (median 1 AR per patient [1–2]). According to the oFASS-5, during OIT-REW, 55.3% of ARs were grade 2, 42.1% grade 3, 1.3% grade 4, and 1.3% grade 5, while all reactions during OIT-BE were grade 2. Differences in the number and severity of reactions between both OIT protocols were statistically significant (p < 0.01).

Conclusion

Baked egg OIT may be a viable alternative for patients with multiple reactions during conventional OIT. Further studies are needed to identify which patients may be candidates for this approach and to assess its long-term effectiveness.